Skip to main content
. 2022 Mar 8;14:100235. doi: 10.1016/j.mtbio.2022.100235

Fig. 4.

Fig. 4

[A] In-vitro wound healing assay images of (a) HaCaT cells obtained at 0, 24 and 48 ​h after wound creation, (b) L929 ​cells obtained at 0, 12 and 24 ​h. Scale bar: 100 ​μm. [B] Percentage wound closure graph of (a) HaCaT cells and (b) L929 ​cells. Results expressed as mean ​± ​SD (n ​= ​3, ∗P ​< ​0.05). Treatments: Control (0.1 ​M PBS, pH 7.4), LLKKK18 – Chitosan NP (LLKKK18 peptide entrapped Chitosan nanoparticles), Tylotoin – Chitosan MP (Tylotoin peptide entrapped Chitosan microparticles), PLGA/Collagen-NF (PLGA/Collagen nanofibers), NF-NP-MP (Bioactive peptides laden nano/micro-sized particles enriched PLGA/Collagen nano-fiber mat).